blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3930794

EP3930794 - A CONTAINER FOR AT LEAST A FIRST INJECTABLE MEDICAMENT AND INJECTION DEVICE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  03.12.2021
Database last updated on 17.09.2024
FormerThe international publication has been made
Status updated on  01.06.2019
Formerunknown
Status updated on  23.11.2018
Most recent event   Tooltip02.10.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Sanofi
54, rue La Boétie
75008 Paris / FR
[2022/01]
Inventor(s)01 / KLEMM, Thomas
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main / DE
[N/P]
Former [2022/01]01 / KLEMM, Thomas
65926 Frankfurt am Main / DE
Representative(s)Weilnau, Carsten, et al
Patentanwälte Sturm Weilnau Franke
Partnerschaft mbB
Unter den Eichen 5 (Haus C-Süd)
65195 Wiesbaden / DE
[2022/01]
Application number, filing date18800672.019.11.2018
[2022/01]
WO2018EP81705
Priority number, dateEP2017030661021.11.2017         Original published format: EP 17306610
[2022/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019101672
Date:31.05.2019
Language:EN
[2019/22]
Type: A1 Application with search report 
No.:EP3930794
Date:05.01.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 31.05.2019 takes the place of the publication of the European patent application.
[2022/01]
Search report(s)International search report - published on:EP31.05.2019
ClassificationIPC:A61M5/24, A61M5/28, A61M5/315, A61M5/178, A61M5/19
[2022/01]
CPC:
A61M5/2459 (EP,US); A61M5/19 (EP,US); A61M5/2425 (EP,US);
A61M5/2448 (EP); A61M5/286 (EP); A61M5/31596 (EP,US);
A61M2005/1787 (EP); A61M2005/2462 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/01]
TitleGerman:BEHÄLTER FÜR MINDESTENS EIN ERSTES INJIZIERBARES MEDIKAMENT UND INJEKTIONSVORRICHTUNG[2022/01]
English:A CONTAINER FOR AT LEAST A FIRST INJECTABLE MEDICAMENT AND INJECTION DEVICE[2022/01]
French:RÉCIPIENT POUR AU MOINS UN PREMIER MÉDICAMENT INJECTABLE ET DISPOSITIF D'INJECTION[2022/01]
Entry into regional phase23.06.2020National basic fee paid 
22.06.2020Designation fee(s) paid 
23.06.2020Examination fee paid 
Examination proceduredeletedDeletion: Application deemed to be withdrawn, date of legal effect  [2022/01]
23.06.2020Examination requested  [2022/01]
23.06.2020Date on which the examining division has become responsible
02.07.2020Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time  [2022/01]
07.06.2022Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to non-payment of the filing fee
16.07.2020Request for further processing filed
16.07.2020Full payment received (date of receipt of payment)
Request granted
27.07.2020Decision despatched
The application is deemed to be withdrawn due to non-payment of the examination fee
16.07.2020Request for further processing filed
16.07.2020Full payment received (date of receipt of payment)
Request granted
27.07.2020Decision despatched
Fees paidRenewal fee
13.11.2020Renewal fee patent year 03
19.10.2021Renewal fee patent year 04
13.10.2022Renewal fee patent year 05
29.09.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]JPH08238324  (NISSHO KK) [X] 1 * figure - * [Y] 2-16;
 [XY]WO0170309  (ANTARES PHARMA INC [US]) [X] 1 * figure 2 * [Y] 2-16;
 [XY]DE10137962  (ROESCH AG MEDIZINTECHNIK [DE]) [X] 1 * page 10, line 12 - page 11, line 8; figure 3 * [Y] 2-16;
 [XY]US2008114304  (NALESSO FEDERICO [IT], et al) [X] 1 * figure 10 * [Y] 2-16;
 [IY]WO2017089280  (SANOFI AVENTIS DEUTSCHLAND [DE]) [I] 1 * figures 2,7A-7C * [Y] 2-16;
 [XY]US2017203051  (MODI PANKAJ [CA], et al) [X] 1 * figures 2-4 * [Y] 2-16;
 [XP]US2018099100  (NAZZARO DAVID [US]) [XP] 1-16* figure - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.